全文获取类型
收费全文 | 6475篇 |
免费 | 487篇 |
国内免费 | 222篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 121篇 |
妇产科学 | 25篇 |
基础医学 | 526篇 |
口腔科学 | 8篇 |
临床医学 | 695篇 |
内科学 | 1614篇 |
皮肤病学 | 34篇 |
神经病学 | 250篇 |
特种医学 | 76篇 |
外科学 | 1168篇 |
综合类 | 789篇 |
预防医学 | 365篇 |
眼科学 | 49篇 |
药学 | 1131篇 |
5篇 | |
中国医学 | 174篇 |
肿瘤学 | 89篇 |
出版年
2023年 | 104篇 |
2022年 | 111篇 |
2021年 | 254篇 |
2020年 | 248篇 |
2019年 | 233篇 |
2018年 | 237篇 |
2017年 | 217篇 |
2016年 | 173篇 |
2015年 | 242篇 |
2014年 | 418篇 |
2013年 | 546篇 |
2012年 | 453篇 |
2011年 | 464篇 |
2010年 | 373篇 |
2009年 | 339篇 |
2008年 | 279篇 |
2007年 | 309篇 |
2006年 | 256篇 |
2005年 | 207篇 |
2004年 | 164篇 |
2003年 | 192篇 |
2002年 | 181篇 |
2001年 | 141篇 |
2000年 | 133篇 |
1999年 | 103篇 |
1998年 | 76篇 |
1997年 | 97篇 |
1996年 | 64篇 |
1995年 | 64篇 |
1994年 | 47篇 |
1993年 | 54篇 |
1992年 | 37篇 |
1991年 | 23篇 |
1990年 | 32篇 |
1989年 | 35篇 |
1988年 | 33篇 |
1987年 | 31篇 |
1986年 | 22篇 |
1985年 | 25篇 |
1984年 | 23篇 |
1983年 | 14篇 |
1982年 | 23篇 |
1981年 | 21篇 |
1980年 | 21篇 |
1979年 | 11篇 |
1978年 | 14篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1974年 | 7篇 |
1973年 | 5篇 |
排序方式: 共有7184条查询结果,搜索用时 15 毫秒
1.
2.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
3.
4.
5.
6.
7.
Ramya Deepthi Vinnakota Allan S. Brett 《The American journal of the medical sciences》2019,357(2):160-163
Iron deficiency anemia is often listed among potential adverse effects of gastric acid-suppressive medications, given that gastric acidity promotes intestinal absorption of nonheme iron. Additionally, the antacid calcium carbonate can inhibit iron absorption. However, there is little direct clinical evidence that proton-pump inhibitors, histamine-2 receptor antagonists, or calcium carbonate cause iron deficiency anemia. Most case reports have had substantial limitations (e.g., minimal follow-up and presence of other causes of iron deficiency), and retrospective cohort studies have lacked sufficient patient-specific detail to make strong causal inferences. We present 2 cases—both with detailed, prospective 10-year follow-up—in which combinations of proton-pump inhibitors, histamine-2 receptor antagonists and calcium carbonate were clearly associated with development of iron deficiency anemia. Overt iron-deficiency anemia is probably uncommon in patients who use acid-modifying medications and who have no other conditions that predispose to iron deficiency. Nevertheless, clinicians should be aware of this potential complication, given widespread use of these agents. 相似文献
8.
9.
《Anaesthesia and Intensive Care Medicine》2020,21(11):548-557
Diabetes is a complex, chronic metabolic disorder affecting approximately 9.3% of the adult population with the estimated number of adults with diabetes worldwide having more than tripled since 2000. This increase has largely been attributed to global urbanization and lifestyle changes. Diabetes affects 10–15% of the surgical population. These patients are frequently elderly, have complex medical co-morbidities and present for both high-risk elective and emergency surgery. This multisystem disease poses a significant challenge to both anaesthesia and surgery with patients with diabetes demonstrating higher morbidity and mortality rates compared to their non-diabetic counterparts. It is crucial that good glycaemic control is maintained throughout the perioperative period as this has been shown to correlate with positive patient outcomes. It is well-recognized that a co-ordinated, multidisciplinary approach aimed at optimizing every point in the patient pathway from GP referral to post-discharge care is required to obtain the best outcomes for the surgical patient with diabetes. The anaesthetist has a key role in the perioperative diabetes multidisciplinary team. Patients themselves are well experienced in manging their own diabetes and should be involved in doing so whenever possible. 相似文献
10.